InsideTrading SEC Form 4 insider trades

Stocks

PRLD Prelude Therapeutics Inc

Healthcare · Market cap: $275.3M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $42.3K, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $146.0K, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $10.1M, sold $81.3K 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $225.7K, sold $0 2025-Q1: bought $648.7K, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $25.0M, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $25.0M) Sold, below the line (largest quarter $81.3K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$42.3K$0
2022-Q3$0$0
2022-Q4$146.0K$0
2023-Q1$0$0
2023-Q2$10.1M$81.3K
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$0
2024-Q4$225.7K$0
2025-Q1$648.7K$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$0$0
2026-Q2$25.0M$0
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$36.3M29 buy days
Sold$911.5K3 sell days
Net insider flow+$35.4Mnet buying · 5 years
Latest trade2026-04-21ORBIMED ADVISORS LLC
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-04-21 Buy ORBIMED ADVISORS LLC Director 2,815,315 $4.44 $12.5M 2
2026-04-21 Buy Bonita David P Director 2,815,315 $4.44 $12.5M 2
2025-03-25 Buy Vaddi Krishna CEO 675,000 $0.69 $465.7K 1
2025-03-25 Buy Combs Andrew Other C-suite 100,000 $0.69 $69.0K 1
2025-03-21 Buy Vaddi Krishna CEO 15,000 $0.73 $11.0K 1
2025-03-20 Buy Vaddi Krishna CEO 5,416 $0.73 $4.0K 1
2025-03-17 Buy Vaddi Krishna CEO 9,106 $0.75 $6.8K 1
2025-03-14 Buy Vaddi Krishna CEO 29,999 $0.75 $22.5K 1
2025-03-13 Buy Vaddi Krishna CEO 50,000 $0.72 $36.0K 1
2025-03-12 Buy Vaddi Krishna CEO 47,500 $0.71 $33.7K 1
2024-12-31 Buy Vaddi Krishna CEO 5,000 $1.21 $6.0K 1
2024-12-30 Buy Vaddi Krishna CEO 10,000 $1.20 $12.0K 1
2024-12-23 Buy Combs Andrew Other C-suite 60,000 $1.37 $82.2K 1
2024-12-20 Buy Combs Andrew Other C-suite 3,075 $1.15 $3.5K 1
2024-12-19 Buy Lim Bryant David CFO 25,000 $0.91 $22.8K 1
2024-12-19 Buy Vaddi Krishna CEO 6,888 $0.89 $6.1K 1
2024-12-18 Buy Vaddi Krishna CEO 100,000 $0.93 $93.0K 1
2023-05-25 Buy Vaddi Krishna CEO 900 $5.31 $4.8K 1
2023-05-24 Buy Lim Bryant David Other C-suite 2,400 $5.39 $12.9K 1
2023-05-24 Buy Vaddi Krishna CEO 1,000 $5.01 $5.0K 1
2023-05-23 Buy Vaddi Krishna CEO 11,856 $5.63 $66.7K 1
2023-05-23 Buy Chardonnet Laurent CFO 5,000 $5.50 $27.5K 1
2023-05-22 Buy ORBIMED ADVISORS LLC Director 869,565 $5.75 $5.0M 1
2023-05-22 Buy Bonita David P Director 869,565 $5.75 $5.0M 1
2023-04-06 Sell Huang Jane President 13,280 $6.12 $81.3K 1
2022-12-20 Buy Vaddi Krishna CEO 19,188 $5.13 $98.4K 1
2022-12-08 Buy Chardonnet Laurent CFO 10,000 $4.76 $47.6K 1
2022-06-01 Buy Chardonnet Laurent CFO 10,000 $4.23 $42.3K 1
2021-12-15 Sell Morosini Deborah Other C-suite 28,751 $13.00 $373.8K 1
2021-12-14 Buy Combs Andrew EVP / SVP 4,000 $11.60 $46.4K 1
2021-12-13 Buy Combs Andrew EVP / SVP 4,000 $12.12 $48.5K 1
2021-11-16 Sell Morosini Deborah Other C-suite 28,751 $15.88 $456.5K 2

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Bonita David P Director $17.5M $0 2026-04-21
ORBIMED ADVISORS LLC Director $17.5M $0 2026-04-21
Vaddi Krishna CEO $871.9K $0 2025-03-25
Morosini Deborah Other C-suite $0 $830.3K 2021-12-15
Combs Andrew Other C-suite $249.6K $0 2025-03-25
Chardonnet Laurent CFO $117.4K $0 2023-05-23
Huang Jane President $0 $81.3K 2023-04-06
Lim Bryant David CFO $35.7K $0 2024-12-19

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2024-12-18 → 2024-12-31 3 $225.7K 55 -13.6% (-11.9% raw)-30.8% (-40.9% raw)-37.0% (-38.5% raw) closed
2023-05-22 → 2023-05-25 5 $10.1M 62 -17.3% (-11.3% raw)-29.9% (-23.1% raw)-41.2% (-37.9% raw) closed
2020-09-25 → 2020-09-29 7 $77.3M 50 +23.4% (+22.5% raw)+153.4% (+165.6% raw)+24.1% (+45.2% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.